Inventor
Peter A. Virsik
Inventor
Portola Valley, CA, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07CAcyclic or carbocyclic compounds20%
A61KPreparations for medical, dental or toiletry purposes16%
C07DHeterocyclic compounds11%
C07BGeneral methods of organic chemistry7%
Y02ATechnologies for adaptation to climate change7%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
PatentTitleYear
11,059,795Androgen receptor modulators and methods for their use202110,945,984Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects202110,940,117Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof202110,716,760Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof202010,624,340Chemical combinations for attracting Vespidae20209,597,292'Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof'20179,452,972'Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof'20168,785,443'Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof'20148,778,991'Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use'20148,258,179'Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use'20128,168,617'Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use'20128,148,414'Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use'20127,994,218'Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use'20117,872,046'Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use'20117,868,043'Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2020Patents assigned to XENOPORT INC (11)· patent assignee history
2011–2021Based in Portola Valley, CA, US· patent location history
2012–2014Patents assigned to VIRSIK PETER A (5)· patent assignee history
2012–2014Patents assigned to ZERANGUE NOA (4)· patent assignee history
2012–2014Patents assigned to DAI XUEDONG (3)· patent assignee history
2020–2021Patents assigned to ARBOR PHARMACEUTICALS LLC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| XENOPORT INC | 11 | 2011–2020 |
| VIRSIK PETER Aself | 5 | 2012–2014 |
| ZERANGUE NOA | 4 | 2012–2014 |
| ARBOR PHARMACEUTICALS LLC | 3 | 2020–2021 |
| DAI XUEDONG | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Portola Valley, California, US | 15 | 2011–2021 |